Parathyroid hormone

DRUG7 trials

Conditions

COVID-19Circulatory FailureCritical IllnessDisruption or Dehiscence of Closure of Sternum or SternotomyMedication related osteonecrosis of the jawMulti Organ FailureOsteoporosisRenal Failure

Phase 2

Parathyroid Hormone (PTH) With Alendronate for Osteoporosis

CompletedNCT00005006

Helen Hayes HospitalOsteoporosis

Start: 1987-09-30End: 2006-12-31Updated: 2015-08-19

Phase 3

Effects of Parathyroid Hormone in Men With Osteoporosis

CompletedNCT00000427

Massachusetts General HospitalOsteoporosis

Start: 1999-09-30End: 2005-10-31Target: 81Updated: 2013-12-09

Treatment With PTH After Sternotomy in Cardiac Surgery Patients

CompletedNCT01466829

University of AarhusDisruption or Dehiscence of Closure of Sternum or Sternotomy

Start: 2012-10-31End: 2014-03-31Updated: 2014-06-02

Phase 4

Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

CompletedNCT00221299

University of California, DavisOsteoporosis

Start: 2005-09-30End: 2009-05-31Updated: 2015-06-25

Unknown Phase

Effect of parathyroid hormone therapy for mediation related osteonecrosis of the jaw.

Active, not recruitingJPRN-UMIN000024896

Yokohama City UniversityMedication related osteonecrosis of the jaw

Start: 2016-03-01Target: 20Updated: 2026-06-29

Parathyroid Hormone Kinetics During CRRT

CompletedNCT03873675

Uniwersytecki Szpital Kliniczny w OpoluCirculatory Failure, Critical Illness, Multi Organ Failure +2

Start: 2019-05-06End: 2020-11-01Updated: 2022-01-14

Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients

CompletedNCT05275491

Aswan University HospitalCOVID-19